1. Bussu F, Rigante M, Giglia V, Bastanza G, De Corso E, Almadori G, et al. Clinical history, prognostic factors, and management of facial nerve in malignant tumors of the parotid gland. Clin Exp Otorhinolaryngol. 2014; Jun. 7(2):126–32.
2. Cracchiolo JR, Shaha AR. Parotidectomy for parotid cancer. Otolaryngol Clin North Am. 2016; Apr. 49(2):415–24.
3. Huang G, Yan G, Wei X, He X. Superficial parotidectomy versus partial superficial parotidectomy in treating benign parotid tumors. Oncol Lett. 2015; Feb. 9(2):887–90.
4. Roh JL, Kim HS, Park CI. Randomized clinical trial comparing partial parotidectomy versus superficial or total parotidectomy. Br J Surg. 2007; Sep. 94(9):1081–7.
5. Slootweg PJ, El-Naggar AK. World Health Organization 4th edition of head and neck tumor classification: insight into the consequential modifications. Virchows Arch. 2018; Mar. 472(3):311–3.
6. Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. AJCC cancer staging manual. Springer; 2017.
7. Bron LP, O’Brien CJ. Facial nerve function after parotidectomy. Arch Otolaryngol Head Neck Surg. 1997; Oct. 123(10):1091–6.
8. Xiao CC, Zhan KY, White-Gilbertson SJ, Day TA. Predictors of nodal metastasis in parotid malignancies: a national cancer data base study of 22,653 patients. Otolaryngol Head Neck Surg. 2016; Jan. 154(1):121–30.
9. Zenga J, Yu Z, Parikh A, Chen JX, Lin DT, Emerick KS, et al. Mucoepidermoid carcinoma of the parotid: very close margins and adjuvant radiotherapy. ORL J Otorhinolaryngol Relat Spec. 2019; 81(1):55–62.
10. Zenga J, Parikh AS, Emerick KS, Lin DT, Faquin WC, Deschler DG. Close margins and adjuvant radiotherapy in acinic cell carcinoma of the parotid gland. JAMA Otolaryngol Head Neck Surg. 2018; Nov. 144(11):1011–6.
11. Stodulski D, Mikaszewski B, Majewska H, Wisniewski P, Stankiewicz C. Close surgical margin after conservative parotidectomy in early stage low-/intermediate-grade parotid carcinoma: outcome of watch and wait policy. Oral Oncol. 2017; May. 68:1–4.
12. Lombardi D, McGurk M, Vander Poorten V, Guzzo M, Accorona R, Rampinelli V, et al. Surgical treatment of salivary malignant tumors. Oral Oncol. 2017; Feb. 65:102–13.
13. Geiger JL, Ismaila N, Beadle B, Caudell JJ, Chau N, Deschler D, et al. Management of salivary gland malignancy: ASCO Guideline. J Clin Oncol. 2021; Jun. 39(17):1909–41.
14. Klussmann JP, Ponert T, Mueller RP, Dienes HP, Guntinas-Lichius O. Patterns of lymph node spread and its influence on outcome in resectable parotid cancer. Eur J Surg Oncol. 2008; Aug. 34(8):932–7.
15. Lim YC, Lee SY, Kim K, Lee JS, Koo BS, Shin HA, et al. Conservative parotidectomy for the treatment of parotid cancers. Oral Oncol. 2005; Nov. 41(10):1021–7.
16. Park YM, Yoon SO, Koh YW, Kim SH, Lim JY, Choi EC. Clinical-pathological prognostic factors and treatment failure patterns in T1-2 high-grade parotid gland cancer. Oral Oncol. 2020; Nov. 110:104884.
17. Lee KC, Chuang SK. Does total parotidectomy improve survival over partial parotidectomy in early-stage adenoid cystic carcinoma of the parotid gland. J Oral Maxillofac Surg. 2022; Sep. 80(9):1550–6.
18. McGurk M, Thomas BL, Renehan AG. Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise. Br J Cancer. 2003; Nov. 89(9):1610–3.
19. Renehan AG, Gleave EN, Slevin NJ, McGurk M. Clinico-pathological and treatment-related factors influencing survival in parotid cancer. Br J Cancer. 1999; Jun. 80(8):1296–300.
20. Carinci F, Farina A, Pelucchi S, Calearo C, Fini-Storchi O, Merlo R, et al. Parotid gland carcinoma: 1987 and 1997 UICC T classifications compared for prognostic accuracy at 5 years. Eur Arch Otorhinolaryngol. 2001; Mar. 258(3):150–4.
21. Gebhardt BJ, Ohr JP, Ferris RL, Duvvuri U, Kim S, Johnson JT, et al. Concurrent chemoradiotherapy in the adjuvant treatment of high-risk primary salivary gland malignancies. Am J Clin Oncol. 2018; Sep. 41(9):888–93.
22. Amini A, Waxweiler TV, Brower JV, Jones BL, McDermott JD, Raben D, et al. Association of adjuvant chemoradiotherapy vs radiotherapy alone with survival in patients with resected major salivary gland carcinoma: data from the National Cancer Data Base. JAMA Otolaryngol Head Neck Surg. 2016; Nov. 142(11):1100–10.